JP2017527557A5 - - Google Patents

Info

Publication number

JP2017527557A5

JP2017527557A5 JP2017510880A JP2017510880A JP2017527557A5 JP 2017527557 A5 JP2017527557 A5 JP 2017527557A5 JP 2017510880 A JP2017510880 A JP 2017510880A JP 2017510880 A JP2017510880 A JP 2017510880A JP 2017527557 A5 JP2017527557 A5 JP 2017527557A5

Authority

JP

Japan

Prior art keywords

seq

protein

mva vector

recombinant

recombinant mva

Prior art date

2015-09-03

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000013598 vector Substances 0.000 claims description 118
• 239000000203 mixture Substances 0.000 claims description 115
• 150000007523 nucleic acids Chemical class 0.000 claims description 61
• 108020004707 nucleic acids Proteins 0.000 claims description 59
• 102000039446 nucleic acids Human genes 0.000 claims description 59
• 230000000890 antigenic effect Effects 0.000 claims description 42
• 241001115402 Ebolavirus Species 0.000 claims description 34
• 101710094648 Coat protein Proteins 0.000 claims description 26
• 239000003937 drug carrier Substances 0.000 claims description 26
• 102000004169 proteins and genes Human genes 0.000 claims description 22
• 108090000623 proteins and genes Proteins 0.000 claims description 22
• 230000037452 priming Effects 0.000 claims description 19
• 229960005486 vaccine Drugs 0.000 claims description 19
• 108090000288 Glycoproteins Proteins 0.000 claims description 18
• 102000003886 Glycoproteins Human genes 0.000 claims description 18
• 239000002773 nucleotide Substances 0.000 claims description 16
• 125000003729 nucleotide group Chemical group 0.000 claims description 16
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 14
• 241001115401 Marburgvirus Species 0.000 claims description 14
• 102000011931 Nucleoproteins Human genes 0.000 claims description 13
• 108010061100 Nucleoproteins Proteins 0.000 claims description 13
• 241001115376 Sudan ebolavirus Species 0.000 claims description 13
• 241001115400 Zaire ebolavirus Species 0.000 claims description 13
• 210000004027 cell Anatomy 0.000 claims description 12
• 101710121417 Envelope glycoprotein Proteins 0.000 claims description 8
• 102100021696 Syncytin-1 Human genes 0.000 claims description 8
• 230000006806 disease prevention Effects 0.000 claims description 8
• 241001115394 Reston ebolavirus Species 0.000 claims description 6
• 241000700605 Viruses Species 0.000 claims description 6
• 108060004795 Methyltransferase Proteins 0.000 claims description 5
• 239000003814 drug Substances 0.000 claims description 5
• 206010001197 Adenocarcinoma of the cervix Diseases 0.000 claims description 2
• 208000034246 Adenocarcinoma of the cervix uteri Diseases 0.000 claims description 2
• 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 claims description 2
• 241000287828 Gallus gallus Species 0.000 claims description 2
• 241000700618 Vaccinia virus Species 0.000 claims description 2
• 239000000654 additive Substances 0.000 claims description 2
• 230000000996 additive effect Effects 0.000 claims description 2
• 210000004102 animal cell Anatomy 0.000 claims description 2
• 238000004113 cell culture Methods 0.000 claims description 2
• 201000006662 cervical adenocarcinoma Diseases 0.000 claims description 2
• 230000000139 costimulatory effect Effects 0.000 claims description 2
• 239000003085 diluting agent Substances 0.000 claims description 2
• 229940079593 drug Drugs 0.000 claims description 2
• 210000002950 fibroblast Anatomy 0.000 claims description 2
• 238000000338 in vitro Methods 0.000 claims description 2
• 210000002510 keratinocyte Anatomy 0.000 claims description 2
• 210000003292 kidney cell Anatomy 0.000 claims description 2
• 210000001161 mammalian embryo Anatomy 0.000 claims description 2
• 201000008968 osteosarcoma Diseases 0.000 claims description 2
• 239000008194 pharmaceutical composition Substances 0.000 claims description 2
• 201000010099 disease Diseases 0.000 claims 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
• 241000711950 Filoviridae Species 0.000 description 84
• 238000000034 method Methods 0.000 description 54
• 102000036639 antigens Human genes 0.000 description 39
• 108091007433 antigens Proteins 0.000 description 39
• 230000028993 immune response Effects 0.000 description 23
• 108700010787 filovirus proteins Proteins 0.000 description 17
• 229940001442 combination vaccine Drugs 0.000 description 11
• 208000000666 Fowlpox Diseases 0.000 description 9
• 230000001681 protective effect Effects 0.000 description 8
• 230000001939 inductive effect Effects 0.000 description 4
• 238000004519 manufacturing process Methods 0.000 description 4
• 230000003612 virological effect Effects 0.000 description 4
• 239000002245 particle Substances 0.000 description 3
• 241000884921 Bundibugyo ebolavirus Species 0.000 description 2
• 241001183012 Modified Vaccinia Ankara virus Species 0.000 description 2
• 108091028043 Nucleic acid sequence Proteins 0.000 description 2
• 230000004927 fusion Effects 0.000 description 2
• 230000036039 immunity Effects 0.000 description 2
• 208000007136 Filoviridae Infections Diseases 0.000 description 1
• 239000004579 marble Substances 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 230000001850 reproductive effect Effects 0.000 description 1